Search Results - "Guadagnino, V"

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community‐based survey in southern Italy by Guadagnino, V, Stroffolini, T, Rapicetta, M, Costantino, A, Kondili, L A, Menniti‐Ippolito, F, Caroleo, B, Costa, C, Griffo, G, Loiacono, L, Pisani, V, Foca, A, Piazza, M

“…In 1996 the prevalence, risk factors, and genotype distribution of hepatitis C virus (HCV) infection were assessed in the general population of a town in…”
Get full text

Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town by Stroffolini, T., Guadagnino, V., Caroleo, B., De Sarro, G., Focà, A., Liberto, M. C., Giancotti, A., Barreca, G. S., Marascio, N., Lombardo, F. L., Staltari, O.

“…Purpose Universal anti-hepatitis B vaccination of infants and of 12-year-old children became mandatory in Italy in 1991. The purpose of this study was to…”
Get full text

Serum transaminase elevations during pegylated interferon treatment of chronic HCV hepatitis probably induced by polyethylene glycol by Caroleo, B, Gallelli, L, Staltari, O, De Sarro, G, Guadagnino, V

“…We report elevated serum alanine aminotransferase (ALT) levels during pegylated interferon (PEG-IFN)-alpha-2a in a patient with chronic HCV without other…”
Get more information

Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users? by Guadagnino, V., Trotta, M.P., Carioti, J., Caroleo, B., Antinori, A.

“…Psychological adverse effects in intravenous drug users represent a challenge in the management of anti-HCV therapy. To evaluate the depressive symptoms during…”
Get full text

Prevalence of non‐organ specific autoantibodies in HCV‐infected subjects in the general population by MURATORI, P., MURATORI, L., STROFFOLINI, T., PAPPAS, G., TERLIZZI, P., FERRARI, R., LOFFREDA, S., CASSANI, F., RAPICETTA, M., GUADAGNINO, V., BIANCHI, F. B., LENZI, M.

“…SUMMARY The significance of non‐organ specific antibodies (NOSAs) in HCV‐related chronic hepatitis is largely unclear. In this study we evaluated the…”
Get full text

929 HEPATITIS C VIRUS INFECTION IN AN ENDEMIC SOUTHERN AREA OF ITALY 14 YEARS LATER: EVIDENCE FOR A VANISHING INFECTION by Guadagnino, V, Stroffolini, T, Caroleo, B, Ippolito, F. Menniti, Rapicetta, M, Ciccaglione, A.R, Chionne, P, Madonna, E, Costantino, A, De Sarro, G, Foca, A, Lentini, M, Staltari, O

Get full text

Bilateral skin ulceration after injection of pegylated interferon-α-2b in a patient with chronic hepatitis C by Gallelli, L, Guadagnino, V, Caroleo, B, Marigliano, N, De Sarro, G.B, Izzi, A

Get full text

Alanine aminotransferase assay to detect anti-HCV positive subjects in non-selected populations by Guadagnino, V, Stroffolini, T, Rapicetta, M, Gulletta, E

Get full text

Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy by Guadagnino, V, Stroffolini, T, Rapicetta, M, Costantino, A, Kondili, LA, Menniti-Ippolito, F, Caroleo, B, Costa, C, Griffo, G, Loiacono, L, Pisani, V, Foca, A, Piazza, M

“…In 1996 the prevalence, risk factors, and genotype distribution of hepatitis C virus (HCV) infection were assessed in the general population of a town in…”
Get full text

T-lymphocyte subpopulations as factors predicting clinical response to interferon in hepatitis C virus-related chronic active hepatitis by Guadagnino, V, Caroleo, B, Izzi, A, De Rosa, G, D'Amelio, R

Get full text

Anti-hepatitis C antibody prevalence among intravenous drug addicts in the Catanzaro area by Guadagnino, V, Zimatore, G, Rocca, A, Montesano, F, Masciari, R, Caroleo, B, Izzi, A, Morabito, D, Naso, E, Scicchitano, R

“…A higher seroprevalence of anti-HCV antibodies (63.4%) was found in 41 intravenous drug addicts (IVDA) when compared to 220 controls (1.8%). Life style is an…”
Get more information

Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy by Guadagnino, V, Zimatore, G, Izzi, A, Caroleo, B, Rocca, A, Montesano, F, Costa, C, Masciari, R, Naso, E, Biselli, R

“…The purpose of this study was to analyze the relationship between intravenous (i.v) drug use practices and the prevalence of human immunodeficiency virus…”
Get more information

A randomized controlled trial of pegylated interferon α-2a (40 KD) or interferon α-2a plus ribavirin and amantadine vs interferon α-2a and ribavirin in treatment-naïve patients with chronic hepatitis C by Mangia, A., Ricci, G. L., Persico, M., Minerva, N., Carretta, V., Bacca, D., Cela, M., Piattelli, M., Annese, M., Maio, G., Conte, D., Guadagnino, V., Pazienza, V., Festi, D., Spirito, F., Andriulli, A.

“…We determined whether triple therapy comprising amantadine (AMA), ribavirin (RBV) and either peginterferon (PEG‐IFN) α‐2a or conventional IFN α‐2a would…”
Get full text

A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C by Mangia, A, Ricci, G L, Persico, M, Minerva, N, Carretta, V, Bacca, D, Cela, M, Piattelli, M, Annese, M, Maio, G, Conte, D, Guadagnino, V, Pazienza, V, Festi, D, Spirito, F, Andriulli, A

“…We determined whether triple therapy comprising amantadine (AMA), ribavirin (RBV) and either peginterferon (PEG-IFN) alpha-2a or conventional IFN alpha-2a…”
Get full text

Identification of HCV genotypes in the Calabria region by Guadagnino, V, Caroleo, B, Zingone, A, Santilli, E, Loiacono, L, Perrotti, N, Tramontano, D

“…The present work describes the distribution of HCV genotypes in Calabria. The data presented suggest that, in the sample of population investigated, genotype…”
Get more information

Acute B Viral Hepatitis Becomes Fulminant After Infection With Hepatitis A Virus by Piazza, M., Guadagnino, V., Orlando, R., Picciotto, L.

Get full text

Determinants of Virologic and Immunologic Outcomes in Chronically HIV-Infected Subjects Undergoing Repeated Treatment Interruptions: The Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study by Palmisano, Lucia, Giuliano, Marina, Bucciardini, Raffaella, Fragola, Vincenzo, Andreotti, Mauro, Galluzzo, Clementina M, Pirillo, Maria F, Weimer, Liliana E, Arcieri, Romano, Germinario, Elena A P, Amici, Roberta, Mancini, Maria Grazia, Monforte, Antonella dʼArminio, Castelli, Francesco, Caramello, Pietro, Vella, Stefano

“…BACKGROUND:Factors influencing the outcome of structured treatment interruptions (STIs) in HIV chronic infection are not fully elucidated. METHODS:In ISS-PART,…”
Get full text

EVIDENZA DI UN GENOTIPO 4 DI HCV IN TOSSICODIPENDENTE PRECEDENTEMENTE HCV POSITIVA (GENOTIPO 1a/1b) ED SVR DOPO TERAPIA CON PEG-IFN + RIBAVIRINA by A. Focà, A. Quirino, G.S. Barreca, A.G. Lamberti, R. Capicotto, C. Di Cello, B. Caroleo, M. Tallarico, V. Guadagnino

Get full text

Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy by Girardi, E, Antonucci, G, Vanacore, P, Palmieri, F, Matteelli, A, Iemoli, E, Carradori, S, Salassa, B, Bruna Pasticci, M, Raviglione, M.C, Ippolito, G, GISTA-SIMIT Study Group

“…Highly active antiretroviral therapy (HAART) greatly reduces the risk of developing tuberculosis for HIV-infected persons. Nonetheless, HIV-associated…”
Get full text

A population based survey of hepatitis B virus infection in a southern Italian town by Stroffolini, T, Guadagnino, V, Chionne, P, Procopio, B, Mazzuca, E G, Quintieri, F, Scerbo, P, Giancotti, A, Nisticò, S, Focà, A, Tosti, M E, Rapicetta, M

“…The level of endemicity and modes of transmission of hepatitis B virus infection may change over time. To assess prevalence of and risk factors for hepatitis B…”
Get more information